Streetbeat News

Stock Prices

CELZ

Creative Medical Technology Holdings (CELZ) was not granted a U.S. patent on Tuesday, contrary to previous reports. This correction clarifies the company's current patent status.

Portfolio Pulse from Charles Gross

January 09, 2024 | 3:53 pm

SHC

Sotera Health's stock price has increased following the company's announcement of its revenue guidance for the fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:53 pm

IBKR

Goldman Sachs analyst James Yaro upgraded Interactive Brokers Group, Inc (NASDAQ:IBKR) from Neutral to Buy and raised the price target from $88 to $102. Despite a recent rally, Yaro believes the market overestimates the company's rate sensitivity and sees potential for earnings to remain stable even with multiple rate cuts. He views the current valuation as an attractive entry point with upside risk.

Portfolio Pulse from Priya Nigam

January 09, 2024 | 3:49 pm

LCII

Truist Securities analyst Michael Swartz has reaffirmed a Buy rating on LCI Industries (NYSE:LCII) and increased the price target from $125 to $140, signaling confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:46 pm

TFC

Truist Finl Inc. (NYSE:TFC) stock dropped by 0.87% to $37.67 in the current market session, with a 10.66% increase over the past month but an 18.62% decrease over the past year. The company's P/E ratio is lower than the Banks industry average, which could indicate either potential undervaluation or a lack of expected future growth. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for investment decisions.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 3:45 pm

GS

UBS analyst Brennan Hawken has reaffirmed a Buy rating on Goldman Sachs Group (NYSE:GS) and increased the price target from $382 to $440.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:45 pm

FUN

Truist Securities analyst Michael Swartz has maintained a Buy rating on Cedar Fair (NYSE:FUN) and increased the price target from $44 to $46.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:44 pm

BBD

Banco Bradesco's stock (BBD) is trading lower following a downgrade from Neutral to Sell by Goldman Sachs, which also set a price target of $3.2.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:37 pm

CAH

Cardinal Health's stock is trading lower following the company's update on its FY24 adjusted EPS guidance and the reiteration of its long-term financial targets. Additionally, Cardinal Health announced a new $250 million share repurchase program set to begin in Q2.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 3:36 pm

MXCT

MaxCyte Inc (NASDAQ:MXCT) shares rose over 9% following the announcement of strong preliminary Q4 and full-year 2023 revenue results, surpassing consensus estimates. Q4 revenue is projected between $15.5 million and $15.7 million, with core revenue between $7.0 million and $7.2 million, and SPL Program-related revenue around $8.5 million. For FY23, revenue is expected to be between $41.1 million and $41.3 million, against a consensus of $36.72 million. The company's cash position as of December 31, 2023, was approximately $210 million. CEO Maher Masoud expressed confidence in the company's future despite a challenging operating environment in 2023. Full Q4 results are anticipated to be released in March 2024.

Portfolio Pulse from Lekha Gupta

January 09, 2024 | 3:35 pm